Literature DB >> 15450687

Exploratory activity, anxiety, and motor coordination in bigenic APPswe + PS1/DeltaE9 mice.

R Lalonde1, H D Kim, K Fukuchi.   

Abstract

Bigenic APPswe + PS1/DeltaE9 mice with Abeta plaque formation in neocortex and hippocampus were evaluated in three tests measuring exploratory activity. By comparison to a non-transgenic group controlled for age and gender, 7-month-old APPswe + PS1/DeltaE9 mice spent more time in the open arms and had higher open/total entries and duration in the elevated plus-maze, indicative of disinhibitory tendencies. On the contrary, the groups did not differ in T-maze and open-field tests. Moreover, the motor coordination of the bigenic group was equivalent to that of controls in stationary beam, coat-hanger, rotorod, and grip strength tests. No mouse displayed neurological signs, such as pathological reflexes, myoclonus, or convulsions. The results in the elevated plus-maze test are akin to the loss of inhibitory control observed in some patients with Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15450687     DOI: 10.1016/j.neulet.2004.07.069

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  40 in total

Review 1.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

2.  Deficits in hippocampal-dependent transfer generalization learning accompany synaptic dysfunction in a mouse model of amyloidosis.

Authors:  Karienn S Montgomery; George Edwards; Yona Levites; Ashok Kumar; Catherine E Myers; Mark A Gluck; Barry Setlow; Jennifer L Bizon
Journal:  Hippocampus       Date:  2015-10-19       Impact factor: 3.899

3.  Characterization of AD-like phenotype in aged APPSwe/PS1dE9 mice.

Authors:  Huang Huang; Sipei Nie; Min Cao; Charles Marshall; Junying Gao; Na Xiao; Gang Hu; Ming Xiao
Journal:  Age (Dordr)       Date:  2016-07-21

Review 4.  Translational Assays for Assessment of Cognition in Rodent Models of Alzheimer's Disease and Dementia.

Authors:  A Shepherd; S Tyebji; A J Hannan; E L Burrows
Journal:  J Mol Neurosci       Date:  2016-09-16       Impact factor: 3.444

5.  Vitamin D2-enriched button mushroom (Agaricus bisporus) improves memory in both wild type and APPswe/PS1dE9 transgenic mice.

Authors:  Louise Bennett; Cindy Kersaitis; Stuart Lance Macaulay; Gerald Münch; Garry Niedermayer; Julie Nigro; Matthew Payne; Paul Sheean; Pascal Vallotton; Dimitrios Zabaras; Michael Bird
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

6.  Activation of PPARA-mediated autophagy reduces Alzheimer disease-like pathology and cognitive decline in a murine model.

Authors:  Rongcan Luo; Ling-Yan Su; Guiyu Li; Jing Yang; Qianjin Liu; Lu-Xiu Yang; Deng-Feng Zhang; Hejiang Zhou; Min Xu; Yu Fan; Jiali Li; Yong-Gang Yao
Journal:  Autophagy       Date:  2019-04-06       Impact factor: 16.016

7.  Intravenous ascorbate improves spatial memory in middle-aged APP/PSEN1 and wild type mice.

Authors:  John A Kennard; Fiona E Harrison
Journal:  Behav Brain Res       Date:  2014-02-05       Impact factor: 3.332

8.  A new tacrine-melatonin hybrid reduces amyloid burden and behavioral deficits in a mouse model of Alzheimer's disease.

Authors:  Carlos Spuch; Desiree Antequera; M Isabel Fernandez-Bachiller; M Isabel Rodríguez-Franco; Eva Carro
Journal:  Neurotox Res       Date:  2009-09-23       Impact factor: 3.911

9.  Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice.

Authors:  David Cheng; Jac Kee Low; Warren Logge; Brett Garner; Tim Karl
Journal:  Psychopharmacology (Berl)       Date:  2014-03-01       Impact factor: 4.530

10.  Vitamin C deficiency increases basal exploratory activity but decreases scopolamine-induced activity in APP/PSEN1 transgenic mice.

Authors:  F E Harrison; J M May; M P McDonald
Journal:  Pharmacol Biochem Behav       Date:  2009-11-24       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.